Literature DB >> 21805441

C4b-binding protein: a forgotten factor in thrombosis and hemostasis.

Björn Dahlbäck1.   

Abstract

Blood coagulation and complement pathways are two important natural defense systems. The high affinity interaction between the anticoagulant vitamin K-dependent protein S and the complement regulator C4b-binding protein (C4BP) is a direct physical link between the two systems. In human plasma, ~70% of total protein S circulates in complex with C4BP; the remaining is free. The anticoagulant activity of protein S is mainly expressed by the free form, although the protein S-C4BP complex has recently been shown to have some anticoagulant activity. The high affinity binding of protein S to C4BP provides C4BP with the ability to bind to negatively charged phospholipid membranes, which serves the purpose of localizing complement regulatory activity close to the membrane. Even though C4BP does not directly affect the coagulation system, it still influences the regulation of blood coagulation through its interaction with protein S. This is particularly important in states of inherited deficiency of protein S where the tight binding of protein S to C4BP results in a pronounced and selective drop in concentration of free protein S, whereas the concentration of protein S in complex with C4BP remains relatively unchanged. This review summarizes the current knowledge on C4BP with respect to its association with thrombosis and hemostasis. © Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21805441     DOI: 10.1055/s-0031-1276584

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  7 in total

1.  Autoimmune diseases and venous thromboembolism: a review of the literature.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Am J Cardiovasc Dis       Date:  2012-07-25

2.  A phase 1 study of the Janus kinase 2 (JAK2)V617F inhibitor, gandotinib (LY2784544), in patients with primary myelofibrosis, polycythemia vera, and essential thrombocythemia.

Authors:  Srdan Verstovsek; Ruben A Mesa; Mohamed E Salama; Li Li; Celine Pitou; Fabio P Nunes; Gregory L Price; Jennifer L Giles; Deborah N D'Souza; Richard A Walgren; Josef T Prchal
Journal:  Leuk Res       Date:  2017-08-31       Impact factor: 3.156

3.  Hemostatic Changes Associated With Increased Mortality Rates in Hospitalized Patients With HIV-Associated Tuberculosis: A Prospective Cohort Study.

Authors:  Saskia Janssen; Charlotte Schutz; Amy M Ward; Mischa A M Huson; Robert J Wilkinson; Rosie Burton; Gary Maartens; Katalin A Wilkinson; Joost C M Meijers; René Lutter; Martin P Grobusch; Graeme Meintjes; Tom van der Poll
Journal:  J Infect Dis       Date:  2017-01-15       Impact factor: 5.226

4.  Protein S Heerlen mutation heterozygosity is associated with venous thrombosis risk.

Authors:  P Suchon; M Germain; A Delluc; D Smadja; X Jouven; B Gyorgy; N Saut; M Ibrahim; J F Deleuze; M C Alessi; P E Morange; D A Trégouët
Journal:  Sci Rep       Date:  2017-04-04       Impact factor: 4.379

5.  Platelet-primed interactions of coagulation and anticoagulation pathways in flow-dependent thrombus formation.

Authors:  Sanne L N Brouns; Johanna P van Geffen; Elena Campello; Frauke Swieringa; Paolo Simioni; Johan W M Heemskerk; Luca Spiezia; René van Oerle; Isabella Provenzale; Remco Verdoold; Richard W Farndale; Kenneth J Clemetson; Henri M H Spronk; Paola E J van der Meijden; Rachel Cavill; Marijke J E Kuijpers; Elisabetta Castoldi
Journal:  Sci Rep       Date:  2020-07-17       Impact factor: 4.379

6.  A Case of Type 2 Protein S Deficiency Presenting as Cerebral Venous Thrombosis (CVT) in an 18-Year-Old Female.

Authors:  Ankush Agarwal S; Jennie Santhanam; Arun K; Sruthi Degapudi; Subramaniyan K
Journal:  Cureus       Date:  2022-08-20

7.  Systematic proteomics analysis of lysine acetylation reveals critical features of placental proteins in pregnant women with preeclampsia.

Authors:  Yu Shangguan; Yinglan Wang; Wei Shi; Ruonan Guo; Zhipeng Zeng; Wenlong Hu; Wanxia Cai; Qiang Yan; Yong Xu; Donge Tang; Yong Dai
Journal:  J Cell Mol Med       Date:  2021-10-26       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.